Investor Relations Home

Webcast ImageWebcast
Q2 2016 Masimo Corporation Earnings Conference Call (Live)
08/03/16 at 1:30 p.m. PT
2014 Annual Report
2014 Annual Report
2012 Annual Report
2012 Annual Report
2011 Annual Report
2011 Annual Report
2009 Annual Report
2009 Annual Report
2008 Annual Report
2008 Annual Report
2007 Annual Report
2007 Annual Report
  
Stock Quote
MASI (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$52.97
Change (%) Stock is Up 0.39 (0.74%)
Volume317,770
Data as of 07/29/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Online Investor Kit
Masimo Reports First Quarter 2016 Financial Results
2015 Form 10K
2016 Proxy Statement
2014 Annual Report
Corporate Profile
We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... 
More >>
Upcoming EventsMore >>
DateTitleAdd to Calendar HelpRemind MePrior to Event
08/03/16 1:30 p.m. PTQ2 2016 Masimo Corporation Earnings Conference CallAdd Q2 2016 Masimo Corporation Earnings Conference Call to Calendar days
Enter your e-mail address 
Recent News
RSS Feeds RSS
| More >>
Leading Ohio Critical Access Hospital Adopts Masimo Root® with Radius-7®, Radical-7®, and Patient SafetyNet™ to Create Hospital-Wide Wireless Monitoring and Clinician Notification System - 07/28/16
GENEVA, Ohio & IRVINE, Calif.--(BUSINESS WIRE)--Jul. 28, 2016-- Masimo (NASDAQ: MASI) announced today that University Hospitals Geneva Medical Center (UH Geneva), a Critical Access Hospital in Geneva, Ohio, is building a ... More >>
New Study Evaluates Masimo PVI® as a Predictor of Fluid Responsiveness in Patients Undergoing Liver Transplantation - 07/21/16
IRVINE, Calif.--(BUSINESS WIRE)--Jul. 21, 2016-- Masimo (NASDAQ: MASI) announced today that a new study of patients undergoing liver transplantation evaluated the relationship of PVI® to right ventricular end-diastolic vol... More >>
Masimo to Report Second Quarter 2016 Financial Results after Market Close on Wednesday, August 3 - 07/20/16
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif.--(BUSINESS WIRE)--Jul. 20, 2016-- Masimo (NASDAQ: MASI) announced today that it will release financial results for the second quarter ended Ju... More >>
New Study Assesses Utility of 1st Generation Masimo Pronto® Pulse CO-Oximeter® with SpHb® Spot Check Technology in Evaluating Pediatric Trauma Patients - 07/14/16
IRVINE, Calif.--(BUSINESS WIRE)--Jul. 14, 2016-- Masimo (NASDAQ: MASI) announced today that in a new study using the 1st Generation Masimo Pronto® Pulse CO-Oximeter®, which noninvasively measures total hemoglobin (SpHb®), ... More >>
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Masimo Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 

To request a copy of the Annual Report, click here.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.